Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade-Reference-Cited by-同舟云学术

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade

Published:2020-01-15 Issue:526 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Nakao Shinsuke¹^ORCID,Arai Yukinori¹,Tasaki Mamoru¹,Yamashita Midori¹^ORCID,Murakami Ryuji¹^ORCID,Kawase Tatsuya¹,Amino Nobuaki¹,Nakatake Motomu²,Kurosaki Hajime²,Mori Masamichi¹,Takeuchi Masahiro¹,Nakamura Takafumi²

Affiliation:

1. Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba 305-8585, Japan.

2. Department of Biomedical Science, Graduate School of Medical Sciences, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.

Abstract

Oncolytic vaccinia virus encoding IL-7 and IL-12 facilitates immune checkpoint blockade in treatment-resistant solid tumors.

Funder

Astellas Pharma Inc

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference61 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

3. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

4. The future of immune checkpoint therapy

5. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer;Journal of Colloid and Interface Science;2024-10

2. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy;European Journal of Pharmacology;2024-10

3. Strategies for engineering oncolytic viruses to enhance cancer immunotherapy;Frontiers in Pharmacology;2024-09-06

4. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01

5. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09